Sequenom Inc. (SQNM)
-NasdaqGS 4.07 
0.16(4.16%) 3:35PM EDT - Nasdaq Real Time Price
| Prev Close: | 3.91 |
|---|
| Open: | 3.90 |
|---|
| Bid: | 4.06 x 1900 |
|---|
| Ask: | 4.07 x 7700 |
|---|
| 1y Target Est: | 7.00 |
|---|
| Beta: | 0.66 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 3.86 - 4.10 |
|---|
| 52wk Range: | 2.65 - 5.36 |
|---|
| Volume: | 3,815,484 |
|---|
| Avg Vol (3m): | 2,770,160 |
|---|
| Market Cap: | 468.95M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.06 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Sequenom: Plenty Of Room To Runat Seeking Alpha(Wed, May 22)
- SEQUENOM INC FinancialsEDGAR Online Financials(Fri, May 17)
- Sequenom's Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)at Seeking Alpha(Thu, May 16)
- Three Monday Upgrades That You May Want to Ignoreat Motley Fool(Wed, May 15)
- Sequenom shares advance as analyst lifts ratingAP(Mon, May 13)
- Did These Healthcare Stocks Miss or Beat Analyst Expectations?at Wall St. Cheat Sheet(Sun, May 12)
- 5 Stocks This Growth-Oriented Hedge Fund Is Most Committed Toat Seeking Alpha(Sun, May 12)
- Sequenom Meets on the Top Line, Misses Where it Countsat Motley Fool(Sat, May 11)
- 3 Humongous Health-Care Stocks This Weekat Motley Fool(Sat, May 11)
- Why Sequenom Shares Jumpedat Motley Fool(Fri, May 10)
- Sequenom's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- Sequenom Earnings: Here’s Why Investors are Buying Shares Nowat Wall St. Cheat Sheet(Thu, May 9)
- Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013PR Newswire(Thu, May 9)
- Sequenom Earnings Preview: Can This Streak Finally End?at Wall St. Cheat Sheet(Thu, May 9)
- SEQUENOM INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Thu, May 9)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 3.97 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.80 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.22 |
|---|
| Mean Recommendation*: | 1.6 |
|---|
| PEG Ratio (5 yr expected): | -0.21 |
|---|
Business Summary
Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
View More